Health Canada approved Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD) in patients ages 4 and older.

Groundbreaking ultrasound technology is revolutionizing cancer treatment, offering non-invasive alternatives to surgery.

Griffith University researchers have shown that the shape and surface chemistry of microscopic "re-entrant" structures—tiny ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation.

The Incucyte ® Cytotoxicity Assay uses the Incucyte ® Cytotox Dyes and the Incucyte ® Live-Cell Analysis System to evaluate ...

The field of cancer research has made significant strides in classifying different types of cancer, but the complexity and ...

A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...

Keloids are raised, overgrown scars that can develop after skin injuries or surgery, often extending beyond the original ...

CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Early research has identified several antigens that could ...

UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that ...

Researchers at MIT and Harvard Medical School found a way to engineer CAR-NK immune cells that makes them much less likely to ...